Darren Cline

Mr. Darren S.
Cline is a Chief Commercial Officer at Xenon Pharmaceuticals, Inc., an Independent Director at Pliant Therapeutics, Inc. and an Independent Director at Pyxis Oncology, Inc. He is on the Board of Directors at Pliant Therapeutics, Inc. and Pyxis Oncology, Inc. Mr. Cline was previously employed as an Independent Director by IPI Legacy Liquidation Co., a President, Chief Executive Officer & Director by Epygenix Therapeutics, Inc., a Chief Commercial Officer by Greenwich Biosciences, Inc., a Chief Commercial Officer-United States by GW Pharmaceuticals Ltd., an Executive Vice President-Commercial by Seattle Genetics, Inc., a Vice President-Market Access by InterMune, Inc., an Executive Director-Sales by Alexion Pharmaceuticals, Inc., and a Marketing Director by Amgen, Inc. He also served on the board at Stemline Therapeutics, Inc., Cascadian Therapeutics LLC and Acadia Realty Trust.
He received his undergraduate degree from San Diego State University and an MBA from Pepperdine Graziadio Business School.